Mandair, Divneet
Reis-Filho, Jorge S. http://orcid.org/0000-0003-2969-3173
Ashworth, Alan http://orcid.org/0000-0003-1446-7878
Article History
Received: 22 July 2022
Accepted: 27 February 2023
First Online: 6 April 2023
Competing interests
: Directly related to the work included in the manuscript: JSR-F reports membership of the scientific advisory board of Paige.AI and receiving personal/consultancy fees and stock options from Paige.AI. AA reports membership of the SAB and stock ownership of Trial Library. Outside the scope of the work included in the manuscript: JSR-F reports receiving consultancy fees from Goldman Sachs, REPARE Therapeutics and Personalis, membership of the scientific advisory boards of VolitionRx, REPARE Therapeutics and Personalis, membership of the Board of Directors of Grupo Oncoclinicas, and ad hoc membership of the scientific advisory boards of Roche Tissue Diagnostics, Ventana Medical Systems, AstraZeneca, Daiichi Sankyo and MSD. AA reports he is the Co-Founder of Tango, Azkarra, OviBio, Kytarro. SAB Member: Genentech, GLAdiator, Cura, Circle, Bluestar, Earli, GSK, Ambagon, PhoenixMD, Yingli, ProLynx. Board Member: Cambridge Science Corp., Cytomx. Grant/Research support from: SPARC, AstraZeneca. He holds patents on the use of PARP inhibitors held jointly with AstraZeneca from which he has benefitted financially (and may do so in the future).